254 related articles for article (PubMed ID: 6345032)
1. Ratios of T lymphocyte subpopulations predict survival of cadaveric renal allografts in adult patients on low dose corticosteroid therapy.
Van Es A; Tanke HJ; Baldwin WM; Oljans PJ; Ploem JS; Vanes LA
Clin Exp Immunol; 1983 Apr; 52(1):13-20. PubMed ID: 6345032
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of T lymphocyte subset ratios for renal transplant survival in patients on different immunosuppressive regimens.
Henny FC; van Es A; Oljans PJ; Baldwin WM; Tanke HJ; van Es LA; Paul LC
Clin Exp Immunol; 1986 Aug; 65(2):373-80. PubMed ID: 3024886
[TBL] [Abstract][Full Text] [Related]
3. Mononuclear cells in renal allografts. Correlation with peripheral blood T lymphocyte subpopulations and graft prognosis.
van Es A; Meyer CJ; Oljans PJ; Tanke HJ; van Es LA
Transplantation; 1984 Feb; 37(2):134-9. PubMed ID: 6364496
[TBL] [Abstract][Full Text] [Related]
4. Alterations in T lymphocyte subpopulations associated with renal allograft rejection.
Stelzer GT; McLeish KR; Lorden RE; Watson SL
Transplantation; 1984 Mar; 37(3):261-4. PubMed ID: 6230781
[TBL] [Abstract][Full Text] [Related]
5. Clinical leukocyte phenotyping by laser flow cytometry and monoclonal antibodies (immunocytometry) in renal transplantation.
Mazaheri R; Stiller CR; Keown PA
Diagn Immunol; 1986; 4(5):257-67. PubMed ID: 2878758
[TBL] [Abstract][Full Text] [Related]
6. Differential recovery of circulating T cell subsets after nodal irradiation for Hodgkin's disease.
Haas GS; Halperin E; Doseretz D; Linggood R; Russell PS; Colvin R; Barrett L; Cosimi AB
J Immunol; 1984 Feb; 132(2):1026-30. PubMed ID: 6361130
[TBL] [Abstract][Full Text] [Related]
7. Serial monitoring of T-cell subset ratios with monoclonal antibodies in steroid- and antithymocyte globulin-treated patients with renal allotransplants.
Lewis RE; Kirchner K; Preuss T; Raju S; Krueger R; Cuchens M; Bower JD; Cruse JM
Clin Immunol Immunopathol; 1984 May; 31(2):241-53. PubMed ID: 6232027
[TBL] [Abstract][Full Text] [Related]
8. The effects of immunomodulation on peripheral T cell subsets.
Chatenoud L; Berrih S; Bene MC; Kreis H; Bach JF
J Clin Immunol; 1982 Jul; 2(3 Suppl):61S-66S. PubMed ID: 6290529
[TBL] [Abstract][Full Text] [Related]
9. Improvement of cadaveric renal allograft survival by thoracic duct drainage: relation with T-lymphocyte subset modifications assessed by flow-cytometry.
Laville M; Cordier G; Brochier J; Lefebvre R; Revillard JP; Traeger J
Proc Eur Dial Transplant Assoc; 1983; 19():488-94. PubMed ID: 6224212
[TBL] [Abstract][Full Text] [Related]
10. Human renal allograft and peripheral blood T lymphocyte subpopulations during the onset and treatment of rejection.
Taube D; Welsh K; Hobby P; Williams DG
Clin Nephrol; 1984 Sep; 22(3):127-32. PubMed ID: 6237816
[TBL] [Abstract][Full Text] [Related]
11. [Immunologic surveillance of liver transplant patients using monoclonal antibodies against lymphocyte subpopulations].
Gugenheim J; Canon C; Samuel D; Saliba F; Debotte G; Misset JL; Mathe G; Bismuth H
Nephrologie; 1987; 8(3):99-101. PubMed ID: 3116444
[TBL] [Abstract][Full Text] [Related]
12. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts.
Cosimi AB; Colvin RB; Burton RC; Rubin RH; Goldstein G; Kung PC; Hansen WP; Delmonico FL; Russell PS
N Engl J Med; 1981 Aug; 305(6):308-14. PubMed ID: 6454075
[TBL] [Abstract][Full Text] [Related]
13. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
[TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin 2 receptor (sIL-2R) levels in renal transplant recipients.
Mehta R; Shah G; Adler W; Kittur D
Clin Transplant; 2004; 18 Suppl 12():67-71. PubMed ID: 15217411
[TBL] [Abstract][Full Text] [Related]
15. Interest in and limitations of monoclonal anti-T-cell antibodies for the follow-up of renal transplant patients.
Chatenoud L; Chkoff N; Kreis H; Bach JF
Transplantation; 1983 Jul; 36(1):45-50. PubMed ID: 6191417
[TBL] [Abstract][Full Text] [Related]
16. Correlation of recipient-donor HLA matching with renal pathology and OKT4+/OKT8+ (4/8) ratio in renal transplant rejection.
Smart YC; Nanra RS; Thomas W; Burton RC
Transplant Proc; 1986 Apr; 18(2):256-9. PubMed ID: 3515660
[No Abstract] [Full Text] [Related]
17. Immunological monitoring of diabetic and nondiabetic recipients of renal allografts.
Delmonico FL; Cosimi AB; Jaffers GJ; Schooley RT; Rubin RH; Tolkoff-Rubin N; Fang LT; Russell PS
J Surg Res; 1983 Oct; 35(4):271-6. PubMed ID: 6225908
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to human T cell subsets: use for immunological monitoring and immunosuppression in renal transplantation.
Burton RC; Cosimi AB; Colvin RB; Rubin RH; Delmonico FL; Goldstein G; Russell PS
J Clin Immunol; 1982 Jul; 2(3 Suppl):142S-147S. PubMed ID: 6290526
[TBL] [Abstract][Full Text] [Related]
19. Rejection episodes and patient and graft survival after renal transplantation.
Finkelstein FO; Lytton B; Schiff M; Black HR
Clin Nephrol; 1975 Jun; 3(6):217-9. PubMed ID: 1095270
[TBL] [Abstract][Full Text] [Related]
20. Equal overall rejection rate in pre-transplant flow-cytometric cross-match negative and positive adult recipients in liver transplantation.
Matinlauri IH; Höckerstedt KA; Isoniemi HM
Clin Transplant; 2005 Oct; 19(5):626-31. PubMed ID: 16146554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
